跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
余 聰
副教授
公共衛生學科暨研究所
https://orcid.org/0000-0002-5773-3665
電話
886 6 2353535 ext 5563
電子郵件
tsungyu
mail.ncku.edu
tw
h-index
1612
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2026
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(109)
類似的個人檔案
(6)
指紋
查看啟用 Tsung Yu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cohort Analysis
100%
Hazard Ratio
45%
Systematic Review
43%
Meta-Analysis
32%
Premature Labor
29%
Cardiovascular Disease
26%
Maturity Onset Diabetes of the Young
26%
Malignant Neoplasm
22%
Body Mass Index
20%
Chronic Obstructive Pulmonary Disease
20%
Overall Survival
19%
COVID-19
18%
Diseases
18%
Particular Matter 2.5
17%
Primary Prevention
17%
COVID-19 Vaccination
17%
Cardiovascular System Cancer
17%
Acetylsalicylic Acid
17%
Disease
17%
Multiple Chronic Conditions
17%
Gestational Hypertension
16%
Infection
16%
Meta-Regression
15%
Gestational Age
15%
Pervasive Developmental Disorder
14%
Retrospective Cohort Study
14%
Maternal Age
14%
Diabetes
14%
Proportional Hazards Model
14%
Patient Preference
13%
Chemoradiotherapy
13%
Pre-Eclampsia
13%
Apoplexy
13%
Maternal Diabetes Mellitus
12%
Decision Making
12%
Prevalence
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Sequela
11%
Cardiovascular System
11%
Breast Cancer
11%
Blood Pressure
11%
Lung
10%
Adjuvant Chemotherapy
10%
Cardiovascular Mortality
10%
Atmospheric Aerosol
10%
Roflumilast
10%
Parental Age
9%
Obstetrics
9%
Cross Sectional Study
9%
Prescription Drug
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
80%
Cardiovascular Disease
65%
All Cause Mortality
36%
Diseases
32%
Malignant Neoplasm
28%
Uveitis
26%
Non Insulin Dependent Diabetes Mellitus
26%
Acetylsalicylic Acid
26%
Infection
24%
SARS Coronavirus
20%
Overall Survival
19%
Long Term Exposure
19%
Cardiovascular System Cancer
19%
Cardiovascular Mortality
18%
Intellectual Impairment
17%
Prospective Cohort Study
17%
Venous Thromboembolism
17%
Open Angle Glaucoma
17%
Chemoradiation Therapy
17%
Anticoagulant Agent
17%
Coronavirinae
16%
Chemotherapy
14%
Rivaroxaban
13%
Cancer Mortality
11%
Coronary Artery Disease
11%
Low Density Lipoprotein Cholesterol
10%
Roflumilast
10%
Premature Labor
9%
Tobacco Dependence
9%
Glaucoma
9%
Bleeding
9%
Maternal Diabetes Mellitus
8%
Tirzepatide
8%
High Density Lipoprotein Cholesterol
8%
Osteocalcin
8%
Nirmatrelvir
8%
Drug Surveillance
8%
Zinc Deficiency
8%
Hypothyroidism
8%
Cardiovascular Risk
8%
Intraocular Hypertension
8%
Prescription Drug
8%
Early Menopause
8%
Herpes Zoster
8%
Leptin
8%
Nasopharynx Cancer
8%
Creatine Kinase
8%
Endometrium Cancer
8%
sodium glucose cotransporter-2 inhibitors
8%
Ritonavir
8%
Keyphrases
Taiwan
33%
Hazard Ratio
25%
Roflumilast
19%
Confidence Interval
19%
All-cause Mortality
19%
Meta-analysis
17%
Network Meta-analysis
17%
Sub-Saharan African Countries
17%
Primary Open-angle Glaucoma
17%
Benefit-risk Assessment
17%
Prospective Cohort Study
17%
Systematic Meta-analysis
17%
Taiwanese
12%
Patient Preference
12%
Osteoporosis
11%
Mortality Hazard
10%
Bone Mineral Density
10%
Clinical Practice Guidelines
10%
Autism Spectrum Disorder
10%
Cardiovascular Disease
10%
Cardiovascular Mortality
9%
Bariatric Metabolic Surgery
8%
Mortality Risk
8%
Randomized Trial
8%
Environmental Scanning
8%
Venous Thromboembolism
8%
Preference Elicitation
8%
African Context
8%
Recurrent Venous Thromboembolism
8%
European Context
8%
Sub-Saharan Africa
8%
COVID-19 Vaccination
8%
Archery
8%
Sleep Practice
8%
Marginal Structural Modeling
8%
Comparison of Estimates
8%
Menopause
8%
Blood Pressure Guidelines
8%
Isolated Systolic Hypertension
8%
Fine Particulate Matter
8%
Isolated Diastolic Hypertension
8%
Long-term Exposure
8%
Risk Stratification
8%
Overall Survival
8%
Cardiovascular Prevention
8%
Physical Activity Determinants
8%
Fluocinolone Acetonide Implant
8%
Pneumonia Mortality
8%
Definitive Concurrent Chemoradiotherapy
8%
Population-based Cohort Study
8%
